Download HISTORY OF ANESIATHIA - International Society for the History

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Pharmacokinetics wikipedia , lookup

Neuropharmacology wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Bad Pharma wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Psychopharmacology wikipedia , lookup

History of general anesthesia wikipedia , lookup

Transcript
HISTORY OF ANESIATHIA
Submitted by
Abdul Nasser Kaadan, MD, PhD*
Basel Ghafeer**
*
Chairman, History of Medicine Department, Institute for the History of Arabic Science,
Aleppo University, Aleppo-Syria
President of ISHIM (www.ishim.net)
P.O. Box: 7581 ,Aleppo ,Syria
e-mail: [email protected]
Phone 963 944 300030, Fax 963 21 2236526
**
Bachelor of Pharmacy, Master stage student, Institute for the History of Arabic Science,
Aleppo University
1
History of anesthesia:
Methods for lessening the sensation of pain during surgery date back to
ancient times. Before the discovery of substances that produced general
anesthesia, patients needing surgery for illness or injury had to rely on alcohol,
opium (a natural narcotic derived from the opium poppy), or fumes from an
anesthetic-soaked cloth to deaden the pain of the surgeon's knife. Often a group
of men held the patient down during an operation in case the opium or alcohol
wore off. Under these conditions, many patients died of shock from the pain of
the operation itself.
Nitrous oxide, ether, and chloroform:
The gases nitrous oxide, ether, and chloroform were first used as
anesthetics in the nineteenth century, ushering in the modern era of anesthesia.
Nitrous oxide, or laughing gas, was discovered as an anesthetic by English
chemist Humphry Davy (1791–1867) in 1799. Davy's finding was ignored until
the next century, when Connecticut dentist Horace Wells (1815–1848) began to
experiment using nitrous oxide as an anesthetic during tooth surgery. In 1845, he
attempted to demonstrate its pain-blocking qualities to a public audience but was
unsuccessful when he began to pull a tooth before the patient was fully
anesthetized. The patient cried out in pain and, as a result, another 20 years
passed before nitrous oxide was accepted for use as an anesthetic.
2
The first use of ether as an anesthetic during an operation was claimed by
surgeon Crawford W. Long (1815–1878) of Georgia in 1842.
The operation, however, was unrecorded, so official credit went instead
to Massachusetts dentist William Morton (1819–1868) for his 1846 public
demonstration of an operation using ether performed in a Boston hospital.
While Morton administered the gas to the patient through an inhaling
device, John C. Warren (1778–1856) removed a neck tumor without the patient
feeling any pain. Following this landmark use of ether as an anesthetic, general
anesthesia began to be practiced all over the United States and Europe.
Chloroform was introduced as a surgical anesthetic by Scottish
obstetrician James Young Simpson (1811–1870) in 1847. After first
experimenting with ether, Simpson searched for an anesthetic that would make
3
childbirth less painful for women. Although it eased the pain of labor,
chloroform had higher risks than those associated with ether. Neither ether nor
chloroform are used in surgery today.
Discovered in 1831, the use of chloroform in anesthesia is linked to James
Young Simpson, who, in a wide-ranging study of organic compounds, found
chloroform's efficacy on 4 November 1847. Its use spread quickly and gained
royal approval in 1853 when John Snow gave it to Queen Victoria during the
birth of Prince Leopold. Unfortunately, chloroform is not as safe an agent as
ether, especially when administered by an untrained practitioner (medical
students, nurses, and occasionally members of the public were often pressed into
giving anesthetics at this time). This led to many deaths from the use of
chloroform that (with hindsight) might have been preventable. The first fatality
directly attributed to chloroform anesthesia was recorded on 28 January 1848
after the death of Hannah Greener.
John Snow of London published articles from May 1848 onwards "On
Narcotism by the Inhalation of Vapours" in the London Medical Gazette. Snow
also involved himself in the production of equipment needed for the
administration of inhalational anesthetics.
4
A nineteenth-century physician administering chloroform prior to surgery. Ether
was one of the earliest anesthetics to be used but it was difficult to administer as
it usually made the patient choke.
Replica of the inhaler Morton used in 1846 during the 1st public demonstration of anesthesia
Anesthetics were administered from the early 1840s, but the impact on
general medical practice began after William Morton publically administered
ether to Gilbert Abbott on 16 October 1846 at Massachusetts General Hospital,
Boston.
On 19 December 1846, Francis Boot, an American botanist who had heard the
news from Boston, watched dental surgeon James Robinson administer the first
ether anesthetic in England. Two days later, Robert Liston operated on Frederick
Churchill at University College Hospital and a medical student, William Squire
administered the anesthetic.
5
Before anesthesia, surgery was a terrifying last resort, a final attempt to save
life. Few operations were possible and surgeons were judged by their speed.
Some doctors had tried using alcohol, morphine and other sedatives to dull the
pain of surgery but most patients were held or strapped down, some luckily
fainted from the agony.
It was more potent but could have severe side effects such as sudden death and
late onset severe liver damage. It became popular because it worked well and
was easier to use than ether. Many died. Anesthesia allowed surgeons to take
more time, be more accurate and undertake more complex procedures.
Emergence of anesthesiology:
Anesthesiology was slow to develop as a medical specialty. By the end of
the nineteenth century, ether—which was considered safer than chloroform—
was administered by persons with little medical experience. Nurses were
eventually assigned to this task, becoming the first anesthetists at the turn of the
century. As surgical techniques progressed in the twentieth century, there was a
corresponding demand for specialists in the area of anesthesia. To meet this
need, the American Society of Anesthetists was formed in 1931, followed by the
American Board of Anesthesiology in 1937, which certified anesthetists as
specialists. In the next 50 years, over 13,000 physicians and nurses were
certified as specialists in the field of anesthesiology.
6
Types of anesthesia:
Modern anesthesia uses both chemical agents and nondrug methods as
preparation for medical procedures. Chemical agents are drugs that can be
administered by mouth, by injection into muscle or under the skin with a needle,
intravenously (by needle into a vein), or with a gas mask for inhalation. They
also come in forms such as creams, gels, or liquids that can be applied or
sprayed directly onto the area being treated. Nondrug methods include
acupuncture (the insertion of fine needles into the body to relieve pain) and the
Lamaze method of natural childbirth, which involves breathing, focusing, and
relaxation techniques to limit pain during labor and delivery.
7
I. General anesthesia:
General anesthesia consists of placing the patient in an initial state of
unconsciousness, keeping the patient unconscious while surgery is being
performed, and bringing the patient back to consciousness after the surgery is
over. A drug commonly used to bring about unconsciousness is thiopentone
sodium, a drug that acts within 30 seconds after being injected intravenously.
The unconscious state is then maintained with other drugs. Inhaled anesthetics
(gases or liquids that change readily into gases) are also used to bring about and
maintain unconsciousness. These include nitrous oxide, halothane, enflurane,
and isoflurane. A combination of barbiturates, nitrous oxide, narcotics (drugs
that cause sleep and relieve pain), and muscle relaxants is often used throughout
the course of an operation. This is usually safer than giving a very large dose of
a single drug that can have serious side effects.
During surgery, the anesthesiologist or anesthetist keeps a constant watch on the
patient's blood pressure, breathing, and heartbeat, and adjusts the levels of
anesthetics being administered as necessary.
II. Local anesthesia:
Local anesthesia was introduced after Carl Koller performed the first
operation using cocaine at the suggestion of Sigmund Freud in 1884. Local
anesthesia is accomplished using drugs that temporarily block the sensation of
pain in a certain area of the body while the patient remains awake. These drugs
act by preventing nerve cells from sending pain messages to the brain. Some
local anesthetics are benzocaine, lidocaine, and procaine (Novocain). They are
used in dental and surgical procedures, medical examinations, and for relieving
minor symptoms such as itching or the pain of toothaches or hemorrhoids.
Spinal anesthesia, sometimes called a saddleblock, is achieved by injecting
anesthetics with a fine needle into the spine, which numbs the abdomen, lower
8
back and legs. It is sometimes used in such procedures as childbirth and hip and
knee surgery.
Plant derivatives:
Throughout Europe, Asia, and the Americas a variety of Solanum species
containing potent tropane alkaloids were used, such as mandrake, henbane,
Datura metel, and Datura inoxia. Ancient Greek and Roman medical texts by
Hippocrates, Theophrastus, Aulus Cornelius Celsus, Pedanius Dioscorides, and
Pliny the Elder discussed the use of opium and Solanum species. In 13th century
Italy, Theodoric Borgognoni used similar mixtures along with opiates to induce
unconsciousness, and treatment with the combined alkaloids proved a mainstay
of anesthesia until the nineteenth century. In the Americas coca was also an
important anesthetic used in trephining operations. Incan shamans chewed coca
leaves and performed operations on the skull while spitting into the wounds they
had inflicted to anesthetize the site. Alcohol was also used, its vasodilatory
properties being unknown. Ancient herbal anesthetics have variously been called
soporifics, anodynes, and narcotics, depending on whether the emphasis is on
producing unconsciousness or relieving pain.
The use of herbal anesthesia had a crucial drawback compared to modern
practice—as lamented by Fallopius, "When soporifics are weak, they are
useless, and when strong, they kill." To overcome this, production was typically
standardized as much as feasible, with production occurring from specific
locations (such as opium from the fields of Thebes in ancient Egypt).
Anesthetics were sometimes administered in the "spongia somnifera", a sponge
into which a large quantity of drug was allowed to dry, from which a saturated
solution could be trickled into the nose of the patient. At least in more recent
centuries, trade was often highly standardized, with the drying and packing of
opium in standard chests, for example. In the 19th century, varying aconitum
9
alkaloids from a variety of species were standardized by testing with guinea
pigs. Trumping this method was the discovery of morphine, a purified alkaloid
that could be injected by hypodermic needle for a consistent dosage. The
enthusiastic reception of morphine led to the foundation of the modern
pharmaceutical industry.
The first effective local anesthetic was cocaine. Isolated in 1859, it was
first used by Karl Koller, at the suggestion of Sigmund Freud, in eye surgery in
1884. German surgeon August Bier (1861–1949) was the first to use cocaine for
intrathecal anesthesia in 1898.
Romanian surgeon Nicolae Racoviceanu-Piteşti (1860–1942) was the first
to use opioids for intrathecal analgesia; he presented his experience in Paris in
1901. A number of newer local anesthetic agents, many of them derivatives of
cocaine, were synthesized in the 20th century, including eucaine (1900),
amylocaine (1904), procaine (1905), and lidocaine (1943).
On 16 October 1846 William Thomas Green Morton, a Boston dentist was
invited to the Massachusetts General Hospital to demonstrate his new technique
for painless surgery. After Morton had induced anesthesia by administration of
10
diethyl ether by inhalation, surgeon John Collins Warren removed a tumor from
the neck of Edward Gilbert Abbott. This first public demonstration of ether
anesthesia occurred in the surgical amphitheater now called the Ether Dome.
The previously skeptical Dr. Warren was impressed and stated "Gentlemen, this
is no humbug." In a letter to Morton shortly thereafter, physician and writer
Oliver Wendell Holmes, Sr. proposed naming the state produced "anesthesia",
and the procedure an "anesthetic".
Morton at first attempted to hide the actual nature of his anesthetic substance,
referring to it as Letheon. He received a US patent for his substance, but news of
the successful anesthetic spread quickly by late 1846. Respected surgeons in
Europe including Liston, Dieffenbach, Pirogov, and Syme, quickly undertook
numerous operations with ether. An American-born physician, Boott,
encouraged London dentist James Robinson to perform a dental procedure on a
Miss Lonsdale. This was the first case of an operator-anesthetist. On the same
day, 19 December 1846, in Dumfries Royal Infirmary, Scotland, a Dr. Scott
used ether for a surgical procedure. The first use of anesthesia in the Southern
Hemisphere took place in Launceston, Tasmania, that same year. Drawbacks
with ether such as excessive vomiting and its flammability led to its replacement
in England with chloroform.
11
Non-pharmacological methods
There is a long history of the use of hypnotism as an anesthetic techniques.
Chilling tissue (e.g. with a mixture of salt and ice or a spray of diethyl ether or
ethyl chloride) can temporarily inhibit the ability of nerve fibers (axons) to
conduct sensation. The hypocapnia that results from hyperventilation can
temporarily inhibit the conscious perception of sensory stimuli, including pain
(see Lamaze technique). These techniques are seldom employed in modern
anesthetic practice.
The early history of spinal anesthesia
The very early development of spinal anesthesia is reviewed, beginning
with J. Leonard Corning’s experience in New York in 1885. August Bier’s first
spinal anesthetic in Germany in 1899 is explored in depth, as are the
contributions of the American physicians Rudolph Matas, F. Dudley Tate and
Guido E. Caglieri.
Spinal anesthesia was described originally by Bier in 1895.1 In 1901,
Bainbridge2 described 12 spinal anesthetics in children aged 4 months to 6 years
using 1e2% cocaine with a dose of 1e2mgkg_1.
Subsequently, Tyrell Grey3,4 reported the experience of 300 stovaine spinal
anesthetics in infants at the Great Ormond Street Hospital. Spinal anesthesia was
described as a safe technique even in gravely ill infants and children. For that
era, the overall mortality rate (1.5%), even in the presence of sepsis, peritonitis
and impending septic shock, was impressively low. The postoperative morbidity
(largely vomiting) was 25% despite infants being fed milk during surgery and
older children being given cake.
Why are not spinals the ‘Gold standard’ of neonatal anesthesia?
12
A 1-year study of 24 409 regional blocks in children by the French-Language
Society of Pediatric
Anesthesiologists (ADARPEF) suggested spinal anesthesia represents
18% of all regional blocks in premature infants and 5% of blocks in term infants
currently <30 days of age. Rochette53 reported 10 929 paediatric regional
anesthetic blocks of which 1042were neonatal spinal anesthetics. Neonatal
spinals represent 30% of all infant neuraxial blocks. Lacroix54 reported
significant decreases in use of caudal anesthesia from 1994 to 2006, but spinal
anesthesia use increased from 2.1% to 3.2% of all regional procedures. In spite
of such widespread use, awake regional techniques are unjustifiably labelled as
having an excessive failure rate, inadequate duration of anesthesia and an
unacceptably high rate of unsettled infants requiring intra-operative sedation.
Emerging data in animalmodels have demonstrated accelerated neuronal
apoptosis and long-term behavioural changes in rodents exposed in the neonatal
period to anesthetic agents that act on N-methyl D-aspartic acid (NMDA) and
gamma aminobutyric acid (GABA) receptors.55 These findings may increase
the use of regional anesthesia in ex-premature infants.
13
The anesthesiologist:
An anesthesiologist is a person who has studied medicine, and is qualified
as a medical practitioner. For all manner of reasons, some of these newly
qualified doctors decide to specialize in the field of anesthesiology, just as other
newly qualified doctors decide to become surgeons, radiologists, internists,
cardiologists, psychiatrists, venerologists, etc. The duration of the specialization
in anesthesiology varies from one country to another, usually lasting from three
to five years, at the end of which the aspiring anesthesiologist must complete a
difficult examination in all aspects of the field of anesthesiology.
The task of the anesthesiologist is not only to anesthetize people so that
they do not feel the pain of surgery, but also to keep the patients under their care
alive in spite of their sometimes life-threatening diseases, and in spite of the
blood loss and/or tissue damage sometimes resulting from major surgery. This is
why well trained anesthesiologists possess a more than average practical
knowledge of the functioning of the human body. Such knowledge enables
anesthesiologists to accurately assess patients to determine their individual risk
14
of anesthesia and surgery, as well as to choose the most appropriate anesthetic
technique for the planned operation for each individual.
1. J. Leonard Corning (1855–1923)
J. Leonard Corning, a New York neurologist, was apparently the first
individual to conceive of the idea of spinal anesthesia. Corning was born in
Connecticut and received both undergraduate and graduate degrees in Germany,
attending the University of Heidelberg and the University of Wu¨rzburg. He was
awarded the degree of doctor of medicine from the University of Wu¨rzburg in
1878. Corning studied the effects of cocaine on the peripheral nervous system
and demonstrated the vasoconstrictive and anesthetic properties of cocaine when
injected subcutaneously.
Corning then went on to study the effects of cocaine on the central nervous
system. Corning hypothesized that if he injected cocaine into the lumbar
vertebral region between two contiguous spinous processes, the drug would be
absorbed by a series of small veins and transported to the spinal cord and cause
loss of both motor and sensory function. He called this condition a ‘‘temporary,
chemical transection of the cord’’. He thus chose an indirect route to achieving
spinal anesthesia, in contrast to the later approach of others such as Bier, who
injected local anesthetic directly into the subarachnoid space.
15
Corning published his work in 1885 in an article entitled ‘‘Spinal Anesthesia
and Local Medication of the Cord ’’. Corning utilized a very large dose of local
anesthetic— 110 mg of 3% cocaine. Fortunately, the drug did not find its way
directly into the subarachnoid space, since it might have proven fatal to the
patient and discouraged others from experimenting with neuraxial anesthesia.
Bier, performing the first true spinal block 14 years later, used only 15 mg of
cocaine for his first patient, and then reduced the dose to 5–10 mg for
subsequent patients .
2. Prerequisites for spinal anesthesia
Many advances took place in medicine in the 14 years after Corning’s
experiments with spinal anesthesia. In Kiel, Germany, beginning in 1872,
Heinrich Irenaeus Quincke (1842–1922) undertook animal experiments
designed to test his theory of relieving elevated intracranial pressure through
lumbar puncture. In 1891, he published a study of 10 patients who underwent 22
lumbar punctures to relieve elevated intracranial pressure associated with
tubercular meningitis .
He designed a spinal needle for this purpose, which bears his name to this
day. In the same year, an English physician,W. Essex Wynter (1860–1945),
published his experience with lumbar puncture. Wynter used a small capillary
tube called a Southey’s tube and a trocar for the procedure. In 1885, the British
Pharmacopoeia set the maximum dose of cocaine hydrochlorate at 65 gm, but
did not indicate the route by which this dose could be administered. The
intrathecal dose of cocaine turned out to be less than this dose—5 to 15 mg
would prove effective.
16
3. Germany—August Bier (1861–1949)
August Bier was born in Helsen in Waldeck in Germany on November
24, 1861. He graduated from medical school in Kiel and became a prominent
surgeon. Bier is credited with performing the first spinal anesthetic. His earliest
work on spinal anesthesia was published in April, 1899 ; he reported six patients
who underwent spinal anesthesia for surgical procedures. The first procedure
was performed on August 16, 1898. Bier used between 5 and 15 mg of cocaine
(either 0.5% or 1.0%). All patients had adequate surgical anesthesia. Five of six
patients complained of post-dural puncture headaches and three suffered from
nausea and vomiting. Bier proved that successful surgical anesthesia could be
provided with subarachnoid cocaine. However, the complication rate was
similar to that for general anesthesia. In order to better understand the risks and
benefits of spinal anesthesia, Bier decided to subject himself to spinal
anesthesia. His associate, Dr. Hildebrandt, performed the lumbar puncture on
Dr. Bier. Unfortunately, the tip of the syringe would not fit properly onto
the hub of the spinal needle; the cocaine was lost, along with a good deal of
cerebrospinal fluid. Undaunted, Dr. Hildebrandt volunteered to be a participant
in the study. In Dr. Hildebrandt’s case, the equipment was checked carefully and
the block was successful. Fifteen milligrams of cocaine was mixed with tap
water and injected intrathecally. What 164 M.G. Mandabach / International
Congress Series 1242 (2002) 163–168 follows in Bier’s paper is a delightful
description of the spinal anesthesia and the creative ways that they used to test
the effectiveness of the block.
Sharp instruments, burning cigars, and strong blows with a hammer were
used. Bier also described the classic symptoms of a post-dural puncture
headache, which for him lasted 9 days. Dr. Hildebrandt suffered from nausea
and vomiting and 4 days of headaches. As noted previously, the cocaine, which
17
they used, was mixed in tap water and no apparent sterilization of drug or
equipment occurred. Possibly, the nausea and vomiting experienced by Dr.
Hildebrandt and their patients was due to a mild form of aseptic meningitis. In
summary, Bier demonstrated that subarachnoid cocaine could provide adequate
anesthesia for surgery despite side effects.
Bier did not endorse the technique enthusiastically, possibly because both
he and Hildebrandt knew first hand of the miserable side effects associated with
the technique. He closed his paper by warning the practitioner to avoid
excessive loss of cerebrospinal fluid.
4. New Orleans, LO—Rudolph Matas (1957- 1860)
Rudolph Matas was born on September 1, 1860 in a small community
near New Orleans, Louisiana. As a young child he lived in Europe; his family
returned to the United States when he was 10 years old. He attended medical
school in New Orleans, graduating from the University of Louisiana in 1880.
Like Bier, Matas was a prominent surgeon.
Dr. Matas is credited with the first published account of spinal anesthesia in the
United States, which he reported in the Journal of the American Medical
Association on December 30, 1899 .
18
Matas had injected 20 mg of cocaine into the subarachnoid space of a 32year-old man for a simple hemorrhoidectomy. Surgery proceeded uneventfully.
Fever, chills, nausea and headache were noted afterwards.
Two weeks prior, Dr. Matas attempted an orthopedic procedure using intrathecal
eucaine B, without success.
5. San Francisco, CA—F. Dudley Tait and Guido E. Caglieri
5.1. F. Dudley Tait (1918-1862)
F. Dudley Tait was born on October 12, 1862. He completed his
secondary education in Europe, returning to New York’s Bellevue Hospital
Medical School where he received his medical degree in 1886. After a brief stint
in private practice, he enrolled in an advanced degree program at the University
of Paris, obtaining his M.D. degree in 1889. He developed an active private
practice, primarily at the French Hospital, which was owned and operated by the
first health maintenance organization in California. An intellectual at heart, he
gravitated towards the newly Affiliated Hospitals of the University of
California, which would later become the University of California, San
Francisco.
5.2. Guido E. Caglieri (1951-1871)
Guido E. Caglieri was born 9 years after F. Dudley Tait, on April 21,
1871. Born into a wealthy banking family, his father was one of the founding
fathers of the Bank of Italy, which would become the Bank of America. Caglieri
received his medical degree from the University of California in 1862. He then
studied in London and Edinburgh, where he
19
attained membership in the Royal College of Surgeons. He returned to practice
in San Francisco and was affiliated with the University of California and the
French Hospital.
Caglieri had many talents; he was active in San Francisco politics, an amateur
geologist, and a practicing physician. He assumed the role of director of the
Bank of America after his father’s death.
5.3. Tait and Caglieri’s work
Tait and Caglieri performed the first spinal anesthetic in the United States.
What brought them together as pioneers in regional anesthesia is unknown.
Perhaps it was a chance meeting at the French Hospital where they both worked.
Tait and Caglieri reported their experience with 11 cases of intrathecal cocaine
for various surgical procedures. Their paper was read before the Medical Society
of the State of California, San Francisco, in April 1900 . In July of 1900, it was
published in the Journal of the American Medical Association. Of the 11
reported spinal anesthetics, 3 were cervical blocks and 8 were lumbar blocks.
Six of 11 blocks resulted in adequate anesthesia, 2 blocks produced marginal
results, and 3 were unsatisfactory.
Tait and Caglieri advocated spinal anesthesia by both the cervical and
lumbar route, not recognizing the risk of damage to the spinal cord associated
with cervical puncture. Even 10 years later, the danger of spinal cord damage
was not universally recognized. The prominent Hungarian surgeon, Thomas
Jonnesco, was an enthusiastic advocate of intrathecal puncture at thoracic and
lumbar levels, preferring puncture at the T1–T2 level for surgery involving the
head, neck, and thoracic regions, and puncture at the T12–L1 level for surgery
on the lower regions of the body. Tait and Caglieri incorrectly attributed post20
dural puncture headaches to an increase in CSF pressure, suggesting that
practitioners limit the amount of drug injected, as well as drawing off a small
amount of CSF before injecting local anesthetic.
Despite these shortcomings, Tait and Caglieri’s work represents an
important contribution to the field of neuraxial anesthesia. However, priority for
performing the first spinal in America is the least significant aspect of their
work. Indeed, they did not even claim priority for the first spinal in America.
They ascribed this to J. Leonard Corning, as noted in the last sentence of their
paper. (No mention is made of the fact that they may have performed the first
spinal in the United States, cited in their paper as occurring on October 26,
1899, about 3 weeks before Matas’ spinal of December 18, 1899.) Instead, they
focused on sharing their experimental and clinical knowledge of the
subarachnoid space.
Tait and Caglieri’s work is a landmark study, revealing what was known at the
time about spinal anesthesia. It is based on the most current clinical and basic
scientific knowledge at the turn of the last century.
21
Spinal anesthesia in the neonate:
Postoperative apnoea in ex-premature infants is inversely proportional to
gestational age at birth and postmenstrual age (PMA). Spinal anesthesia is an
important technique in ex-premature infants as it reduces the risk of
postoperative apnoea, provided intra-operative sedation is avoided. Recent
studies have provided more data on recommended doses of local anesthetics for
infant spinal anesthesia as well as adjuvants used to prolong the duration of
surgical anesthesia. Spinal anesthesia is also used for surgical procedures other
than inguinal hernia repair. There are a variety of reasons why awake regional is
not the preferred technique for ex-premature infants undergoing lower
abdominal surgery in many centres, and there is also controversy over the
appropriate anesthetic technique for outpatient surgery in infants <60 weeks
PMA. A pragmatic decision analysis on the selection of anesthetic techniques
for inguinal hernia repair in infants is presented.
So: Infant spinal anesthesia offers significant benefits to ex-premature
infants who are at risk of postoperative apnoea. Infants most likely to benefit
include term infants currently <45 weeks PMA and ex-premature infants
between 45 and 60 weeks PMA. Recent studies have demonstrated a 98%
success rate in performance of the block, but this success rate cannot be
expected to be replicated in units where awake regional techniques are
uncommonly performed. Even in centres with long-standing experience in spinal
anesthesia, there is a significant incidence of infants requiring intra-operative
sedation or supplementation of the block when surgical duration exceeds 75
min. All currently available local anesthetic agents have now been described for
infant spinal anesthesia with the choice of agent determined by institutional
preference. Attempts to increase the duration of motor block by addition of a2
agonists, such as clonidine, have been hampered by a significant incidence of
22
postoperative sedation and apnoeas. Despite strong opinions for and against
awake regional techniques, there are limited studies comparing spinal anesthesia
to general anesthesia with modern agents such as desflurane or sevoflurane and
no studies comparing awake caudal anesthesia to awake spinal anesthesia. On
current evidence, there is no anesthetic technique which reliably reduces the
apnoeic risk in ex premature infants to a level which would allow lower
abdominal surgery day-case surgery in ex-premature infants.
Spinal anesthesia was first performed by August Bier in Germany in
1889. However, its earliest roots can be traced to J. Leonard Corning, a New
York neurologist who conceived of the idea of spinal anesthesia by
administering cocaine in the central nervous system.
Rudolf Matas first published a case report on spinal anesthesia in the United
States in 1899, followed shortly thereafter by the publication of Tate and
Caglieri’s study of the subarachnoid space and their experience with spinal
anesthesia. In the 2 years after Bier’s report was published, over 1000 articles on
spinal anesthesia appeared in the literature. As in other developments in regional
anesthesia, spinal anesthesia appeared in many areas of the world at about the
same time. Six months after Bier’s work was published (October 1899), Dr. J.B.
Seldowitsch, in St. Petersburg, Russia, reported four cases of spinal anesthesia
for lower extremity surgery. Tuffier, in France, published his studies in
November 1899. These studies were little more than case reports, offering no
solutions for the troubling side effects associated with the technique. With the
development of safer drugs, sterile equipment, and aseptic techniques, spinal
anesthesia would earn a place in the armamentarium of most practicing
anesthesiologists. These early pioneers led the way, and others would follow and
improve the technique.
23
Biopharmaceutical, Anesthesia
We supply best biopharmaceutical products. The medicinal products are
formulated by direct extraction from a native (non-engineered) biological source
using biotechnology. The biopharmaceutical products are the derivatives of
living forms. The products are nucleic acids (DNA, RNA or antisense
oligonucleotides) and proteins (including antibodies). It finds application for
therapeutic or vivo diagnostic purposes.We also offer anesthesia products,
which are widely used in the pharmaceutical industry. Common anesthesia is to
introduce a balanced state of unconsciousness along with the absence of any
kind of pain sensation. It also temporarily paralyze skeletal muscle all over the
body. It is done through injecting anesthetic drugs in the body of the patient in
the duration of major surgery and other invasive surgical procedures. The
General anesthesia products provide following signs in the body after its
consumption:
� Analgesia, or pain relief
� Amnesia, or loss of memory of the procedure
� Motionlessness
� Loss of consciousness
� Weakening of autonomic responses
Pharmacokinetic principles:
Pharmacokinetics can be defined as the characterization and prediction of
the time course of the concentration of a drug in the body. This includes the
characteristics of drug absorption, distribution, metabolism and elimination.
Pharmacokinetic models can be used to predict the time course of this drug
concentration. Variations in body composition or organ function — for example,
in children, in pregnant women and fetuses in utero, in elderly populations and
in patients with organ dysfunction — may affect anaesthetic drug distribution
24
and elimination and therefore drug responses. In this chapter, we first briefly
describe some of the basic concepts governing pharmacokinetics. Secondly, we
focus on the concepts of pharmacokinetic modelling and, thirdly, the influence
of various physiological changes on the pharmacokinetics of drugs is described.
Pharmacodynamics:
Pharmacodynamics describes the way in which a drug effects change in
the body. There is a number of ways in which this can happen: as a result of
physicochemical interaction, such as the acid-neutralizing effect of sodium
citrate or as a result of enzyme inhibition, such as the anti-infl ammatory effects
of aspirin on cyclo-oxygenase enzymes. However, many drugs interact
specifically with endogenous receptors, macromolecules that act as signal
transducers between drug binding and response. The term ‘receptive substance’
was first used by Langley at the end of the 19th century. Many drugs of
importance to the anesthetist interact with receptors; for example propofol and
iso flurane act at central GABAA receptors and neuromuscular blocking agents
prevent the action of acetylcholine (A Ch) at the nicotinic cholinergic receptors
at the motor endplate. With modern technological advances both in X-ray
crystallography and gene sequencing, we now know the three-dimensional
structure and amino acid sequences of many receptors. Some are multisubunit
Trans-membrane proteins that are associated with very rapid response signalling
due to ion channel opening, as are the nicotinic ACh and GABAA receptors.
There is also a very large number of heptahelical trans-membrane receptors that
require coupling with secondary proteins, G-proteins, before signal transduction
can be effected: opioid drugs such as morphine act through such G-proteincoupled receptors (GPCRs). Still other trans-membrane proteins have integral
enzyme activity associated with their cytosolic face that is activated by
25
extracellular ligand binding; for example, the tyrosine kinase activity associated
with the receptor for insulin. Although we understand the three-dimensional
structure of many such receptors, we must also be able to describe the dynamics
of drug–receptor interaction.
As we will see later, there may be very different effects observed for
transient compared with chronic exposure of a receptor to a given drug
concentration.
Mechanisms of anesthesia: a role for voltage-gated K channels?
The mechanisms of how general anesthetics induce unconsciousness are little
known. This is surprising considering the fact that general anesthesia was
introduced more than 150 years ago, when Crawford Long performed the first
surgical operation with ether anesthesia.
The lack of knowledge concerning anesthetic mechanisms pertains to all levels
of brain organization.
At the macroscopic level, we have knowledge about a number of brain
structures that are affected by general anesthetics but we have little detailed
knowledge about which structures are critical for anesthesia. Similarly, at the
mesoscopic level, we know how anesthetics modulate cellular processes in a
number of systems but not which modifications are critical. At the microscopic
level, we know how anesthetics phenomenologically affect membrane
proteins, but not by which molecular mechanisms and not which membrane
proteins are critically affected.
26
Consequently, we do not know how these interact to produce anesthesia.
One of the problems complicating the determination of the anaesthetic
mechanisms at all levels is the fact that anesthetics form a very diverse chemical
group. General anesthetics comprise: chemically unrelated compounds such as
nitrous oxide, diethyl ether, halogenated hydrocarbons, alcohols, barbiturates,
and ketamine and propofol. Does this imply that anesthesia is caused by many
different mechanisms? It seems so, and consequently a unitary theory, once
dominant, now appears obsolete.
The difficulty in solving the general anesthesia problem is highlighted by
its close connection to the consciousness problem, one of the greatest challenges
to human rationality. We do not know which brain structures cause conscious
processes, which cellular activity is associated with experiencing or which
physical brain processes correlate critically with mental activity.
The main aim of this chapter is to summarize briefly some aspects of current
knowledge about the function of general anesthetics at different organization
levels. In particular, we highlight the possible role of voltage-gated K channels
as targets for anesthetics.
Popular perceptions
General anesthesia has somehow acquired very bad publicity in many
modern Western countries. In my personal experience this may even be
expressed in the rather extreme attitude; "It's OK to die as a result of the
operation, but it's not OK to die as a result of the general anesthesia needed to
make the operation possible!" A colleague of mine, Professor Anneke Meursing,
also once expressed this attitude in a pithy little sentence; "The surgeon gets
flowers, and the anesthesiologist gets sued."
27
Many people also seem to think that general anesthesia is only administered by
nurses, or even the hospital porter - a sort of surgical appendage, doing only
what the surgeon wants, and when the surgeon wants it. Many people even
believe general anesthesia and death to be similar conditions - accordingly,
general anesthesia is considered an extremely dangerous condition indeed. I will
discuss these perceptions, as well as some of the lesser known consequences of
general anesthesia.
Finally
This article is intended to give interested readers more insight into how
anesthesia works, to explain some popular misconceptions, to illustrate some of
the more suprising experiences reported by people undergoing anesthesia, as
well as to provide information to trainee anesthesiologists on subjects seldom, or
inadequately discussed in most textbooks or during their training.
Which in turn led to the introduction of infiltration anesthesia, nerve blocks,
spinal and epidural anesthesia, then at the turn of the century came control of the
airway using tubes placed in the trachea to help breathing.
By the 1920's intravenous induction agents were introduced which enabled
patients to fall asleep quickly and pleasantly. Muscle relaxants were introduced
in the 1940s.
Today, anesthetists are highly trained and skilled physicians who provide a wide
range of patient care.
They often run High Dependency and Intensive Care
Units. They are involved in obstetric analgesia and anesthesia, emergency
medicine in A & E departments, resuscitation, major accident care, pain
management and patient transfers between hospitals.
28
Anesthesia is now very safe, with mortality of less than 1 in 250,000
directly related to anesthesia.
Nevertheless with today's sophisticated
monitoring systems and a greater understanding of bodily functions, the
anaesthetic profession will continue to strive for improvement over the next 150
years.
References:
1. Morris Fishbein, ed (1976). "Anesthesia". The New Illustrated Medical
and Health Encyclopedia. 1 (Home Library Edition ed.). New York: H. S.
Stuttman Co. pp. 87–9.
2. Career as an anaesthesiologist. Institute for career research. 2007. p. 1.
http://www.google.com/books?id=vQb5LnDI5CoC&dq=anesthesia+ancie
nt&lr=&as_brr=3&source=gbs_navlinks_s. Retrieved 2010-11-25.
3. Brill S, Gurman GM and Fisher A (2003). "A history of neuraxial
administration of local analgesics and opioids". European Journal of
Anaesthesiology 20 (9): 682–9.
4. Fenster, JM (2001). Ether Day: The Strange Tale of America's Greatest
Medical Discovery and the Haunted Men Who Made It. New York:
HarperCollins. ISBN 9780060195236.
5. "Nurse anesthesia worldwide: practice, education and regulation".
International Federation of Nurse Anesthetists. http://ifnaint.org/ifna/e107_files/downloads/Practice.pdf. Retrieved 2010-11-25.
6. "Is Physician Anesthesia Cost-Effective?". Anesthesia and Analgesia.
2007. http://www.anesthesia-analgesia.org/cgi/content/full/98/3/750#R7138848. Retrieved 2010-11-25.
7. Rosenbach, ML; Cromwell, J (2007). "When do anesthesiologists
delegate?". Med Care 27 (5): 453–65.
8. "Nurse anestheisa worldwide: practice, education and regulation".
International Federation of Nurse Anesthetists. http://ifnaint.org/ifna/e107_files/downloads/Practice.pdf. Retrieved 2010-11-25.
9. "Surgical mortality and type of anesthesia provider". AANA. 2007.
http://www.aana.com/news.aspx?ucNavMenu_TSMenuTargetID=171&u
cNavMenu_TSMenuTargetType=4&ucNavMenu_TSMenuID=6&id=160
6&terms=medical+direction+percent&searchtype=1&fragment=True.
Retrieved 2010-11-25.
10. "Anesthesia Providers, Patient Outcomes, and Cost". Anesthesia and
Analgesia,2007.
29
http://nursing.fiu.edu/anesthesiology/COURSES/Semester%203/NGR%2
06760%20ANE%20Prof%20Aspects/PROF%20Readings/Abenstein.pdf.
Retrieved 2010-11-25.
11. ACGME Program Requirements for Graduate Medical Education in
Anesthesiology, Effective: July 1, 2008
12. "ASA Fast Facts: Anesthesiologists Provide Or Participate In 90
Percent
Of
All
Annual
Anesthetics".
ASA.
http://www.asahq.org/PressRoom/homepage.html. Retrieved 2010-11-25.
13. "Johns
Hopkins
Medicine
Simulation
Center".
http://www.hopkinsmedicine.org/simulation_center/index.html. Retrieved
2010-11-25.
14. "The Center for Medical Simulation". Cambridge, Massachusetts.
2009. http://www.harvardmedsim.org/. Retrieved 2010-11-25.
15. "MedSim-Eagle Patient Simulator – Simulation Center". Stanford
University
School
of
Medicine.
http://med.stanford.edu/VAsimulator/medsim.html. Retrieved 2010-1125.
16. "Mount
Sinai
Simulation
HELPS
Center".
http://msmc.affinitymembers.net/simulator/intro2.html. Retrieved 201011-25.
17. "Simcenter". http://simcenter.duke.edu/. Retrieved 2010-11-25.
18. About. AANA. Retrieved on 2010-09-29.
19. Becoming a CRNA. AANA. Retrieved on 2010-09-29.
20. Fact Sheet: Concerning State Opt Outs. AANA. Retrieved on 2010-09-29.
21. Centers for Medicare and Medicaid Services, Department of Health and
Human Services (2010). "Chapter 12, Section 50: Payment for
Anesthesiology Services". Medicare Claims Processing Manual.
Washington, DC: U.S. Government Printing Office. pp. 116–23.
http://www.cms.gov/manuals/downloads/clm104c12.pdf. Retrieved 201011-25.
22. Centers for Medicare and Medicaid Services, Department of Health and
Human Services (2002). "IV: 42CFR482.52: Condition of
participation: Anesthesia services". Code of Federal Regulations, Title
42. 3. Washington, DC: U.S. Government Printing Office. pp. 490–1.
http://edocket.access.gpo.gov/cfr_2002/octqtr/42cfr482.52.htm. Retrieved
2010-11-25.
23. Centers for Medicare and Medicaid Services (2010). "Conditions for
Coverage (CfCs) & Conditions of Participations (CoPs): Spotlight".
30
Washington, DC: Centers for Medicare and Medicaid Services.
http://www.cms.gov/CFCsAndCoPs/02_Spotlight.asp. Retrieved 201011-25.
24. "Five facts about AAs". American Academy of Anesthesiologist
Assistants.
Archived
from
the
original
on
2006-09-26.
http://web.archive.org/web/20060926091707/http://www.anesthetist.org/c
ontent/view/14/38/. Retrieved 2010-11-25.
25. "ASATT Certification Information". American Society of Anesthesia
Technologists & Technicians. http://www.asatt.org/cert.html. Retrieved
2010-11-25.
26. New Zealand Anaesthetic Technicians Society
27. Baillie, JK; P. Sultan, E. Graveling, C. Forrest, C. Lafong (2007).
"Contamination of anaesthetic machines with pathogenic
organisms". Anaesthesia 62 (12): 1257–61.
28. Scott, DHT; S Fraser, P Willson, G B Drummond, J K Baillie (2010).
"Passage of pathogenic microorganisms through breathing system
filters used in anaesthesia and intensive care". Anaesthesia 65 (7):
670–3.
29. STANDARDS FOR BASIC ANESTHETIC MONITORING. Committee
of Origin: Standards and Practice Parameters (Approved by the ASA
House of Delegates on October 21, 1986, and last amended on October
20, 2010 with an effective date of July 1, 2011)
30. Stoelting RK, Miller RD: Basics of Anesthesia, 3rd edition, 1994.
31. doi:10.1213/ane.0b013e31818322d2.
32. Gillerman, RG; Browning, RA (2000). "Drug use inefficiency: a hidden
source of wasted health care dollars". Anesthesia and Analgesia 91 (4):
921–4.
33. Reich, DL; Kahn, RA; Wax, D; Palvia, T; Galati, M; Krol, M (2006).
"Development of a module for point-of-care charge capture and
submission using an anesthesia information management system".
Anesthesiology 105 (1): 179–86; quiz 231–2.
34. Martin, J; Ederle, D; Milewski, P (2002). "CompuRecord-A
perioperative information management-system for anesthesia".
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
37 (8): 488–91.
35. Meyer-Jark, T; Reissmann, H; Schuster, M; Raetzell, M; Rösler, L;
Petersen, F; Liedtke, S; Steinfath, M et al. (2007). "Realisation of
31
material costs in anaesthesia. Alternatives to the reimbursement via
diagnosis-related groups". Der Anaesthesist 56 (4): 353–5.
36. Cook, RI; McDonald, JS; Nunziata, E (1989). "Differences between
handwritten and automatic blood pressure records". Anesthesiology
71 (3): 385–90.
37. Devitt, JH; Rapanos, T; Kurrek, M; Cohen, MM; Shaw, M (1999). "The
anesthetic record: accuracy and completeness". Canadian Journal of
Anesthesia 46 (2): 122–8.
38. Edsall, DW (1991). "Computerization of anesthesia information
management—users' perspective". Journal of Clinical Monitoring 7
(4): 351–8.
39. Merry AF, Webster CS, Mathew DJ (2001). "A new, safety-oriented,
integrated drug administration and automated anesthesia record
system". Anesthesia and Analgesia 93: 385–90. http://www.anesthesiaanalgesia.org/content/93/2/385.full. Retrieved 2010-11-25.
40. O'Reilly, M; Talsma, A; Vanriper, S; Kheterpal, S; Burney, R (2006).
"An anesthesia information system designed to provide physicianspecific feedback improves timely administration of prophylactic
antibiotics". Anesthesia and Analgesia 103 (4): 908–12.
41. Hollenberg, JP; Pirraglia, PA; Williams-Russo, P; Hartman, GS; Gold, JP;
Yao, FS; Thomas, SJ (1997). "Computerized data collection in the
operating room during coronary artery bypass surgery: a comparison
to the hand-written anesthesia record". Journal of Cardiothoracic and
Vascular Anesthesia 11 (5): 545–51.
42. Röhrig, R; Junger, A; Hartmann, B; Klasen, J; Quinzio, L; Jost, A;
Benson, M; Hempelmann, G (2004). "The incidence and prediction of
automatically detected intraoperative cardiovascular events in
noncardiac surgery". Anesthesia and Analgesia 98 (3): 569–77.
43. Feldman, JM (2004). "Do anesthesia information systems increase
malpractice exposure? Results of a survey". Anesthesia and Analgesia
99 (3): 840–3.
44. Epstein, RH; Gratch, DM; Grunwald, Z (2007). "Development of a
scheduled drug diversion surveillance system based on an analysis of
atypical drug transactions". Anesthesia and Analgesia 105 (4): 1053–
60, table of contents.
45. Anesthesia - History Of Anesthesia, Nitrous Oxide, Chloroform,
Ether. http://science.jrank.org/pages/363/Anesthesia.html
46. J.L. Corning, Spinal anaesthesia and local medication of the cord, N.
Y. Med. J. 42 (1885) 483– 485.
32
47.H.I. Quincke, Die Lumbalpunction des Hydrocephalus, Berl. Klin.
Wochenschr., 28 (1891) 929 – 931, 965– 968.
48.W.E. Wynter, Four cases of tubercular meningitis in which
paracentesis of the theca vertebralis was performed for the relief of
fluid pressure, Lancet, (1891) 981– 982.
49.B.R. Fink, The first ‘‘spinal’’ anesthesia a lucky failure, in: B.R. Fink,
L.E. Morris, C.R. Stephen (Eds.), The History of Anesthesia Third
International Symposium, 1992, pp. 169–170.
50.A. Bier, Versuche u¨ber Cocainisirung des Ruckesmarkes, Dtsch. Z. Chir.
51 (1899) 361– 369.
51. A. Matas, Intraspinal cocainization, JAMA 33 (1899) 1659.
52.D. Tait, G. Caglieri, Experimental and clinical notes on the
subarachnoid space, Trans. Med. Soc. State Calif. (April 1900) 266–271.
53.D. Tait, G. Caglieri, Experimental and clinical notes on the
subarachnoid space, JAMA 35 (1900) 6– 10.
54. T. Jonnesco, Remarks on general spinal anesthesia, Br. Med. J. 2
(1909) 1396– 1401.
55.M.D. Larsen, Tait and Caglieri the first spinal anesthetic in America,
Anesthesiology 85 (4) (1996) 913–919.
56. Anonymous, Surgical anaesthesia by the injection of cocaine into the
lumbar subarachnoid space, Lancet, (1901) 188– 196.
57. J.B. Seldowitsch, U¨ ber cocainisirung des Ru¨chenmartks nach Bier,
Centralblatt Chir. 26 (1899) 1110–1113.
58. T. Tuffier, Analge´sie Chirurgicale par l’injection sousarachnoı¨dienne
lombaire de cocaı¨ne, Soc. Biol. (Nov. 11, 1899) 882–884.
59.T. Tuffier, Analgesie Chirurgicale par l’injection de cocaı¨ne sous
l’arachnoide lombaire, Presse Med. 91 (1899) 294– 295.
33
‫ملخص البحث‪:‬‬
‫اجتهد العلماء قديما في البحث عن حل لتسكين اآلالم الحادة التي يعاني منها‬
‫المريض الذي تضطره الظروف للخضوع إلجراء العمليات الجراحية‪ ،‬فأسفرت بعض األبحاث‬
‫عن استخدام بعض األعشاب التي تقلل من اإلحساس باأللم مثل األفيون‪ ،‬والقنب وغيرها‬
‫ولكنها لم تقضي على األلم نهائيا نظ ار الستخدامها بتركيزات قليلة ألن الكثير منها يفضي‬
‫إلى الموت‪ ،‬ثم جاءت المشروبات الكحولية كوسيلة لتخفيف األلم ولكن المريض ما يلبث أن‬
‫يشعر باأللم ويسترد وعيه‪ ،‬كما حاول البعض إفقاد المريض لوعيه حتى يتم االنتهاء من‬
‫العملية‪ ،‬وأيضا استخدام التنويم المغناطيسي‪ ،‬وقام الصينيون باستخدام اإلبر للتحكم في‬
‫األلم‪ ،‬وغيرها الكثير من الوسائل التي لم تحقق الكثير من النجاح وكان لكي يتم إجراء عملية‬
‫لمريض يجب تقييده جيدا على منضدة العمليات حتى يتم االنتهاء من العملية‪ ،‬وكان الكثير‬
‫من العمليات ينتهي بوفاة المريض‪.‬‬
‫بدأ التخدير يأخذ شكل أخر بداية من أواخر القرن الثامن عشر‪ ،‬فاكتشف الكيميائي‬
‫بريستلي غاز أكسيد النيتروز والذي له تأثير مخفف لأللم‪ ،‬كما اكتشف مايكل فاراداي أن‬
‫استنشاق غاز األثير له تأثير يسبب فقدان اإلحساس باأللم‪.‬‬
‫وتوصل د‪ .‬هوارس ويلز إلى استخدام "الغاز المضحك" أو أكسيد النيتروز كوسيلة للتخدير‬
‫أثناء إجراء جراحات األسنان‪ ،‬ولكن لم يكتب لويلز النجاح في عرض تجاربه أمام األطباء‪.‬‬
‫جاء دور مورتون بعد ذلك والذي توصل إلى أن "الغاز المضحك" ليس وسيلة فعالة في‬
‫تخفيف أالم المرضى أثناء إجراء العمليات الجراحية‪ ،‬فلجأ إلى استخدام "األثير" والذي عرف‬
‫عنه أن له خواص خافضة لأللم ومفقدة لإلحساس‪.‬‬
‫‪34‬‬